Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    2.

    Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

    Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

    Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299. PMID: 11453706 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Using a type of blood pressure medicine, angiotensin-converting enzyme inhibitors, to prevent worsening of kidney disease unrelated to diabetes.

    ACE Inhibition in Progressive Renal Disease Study Group.

    Ann Intern Med. 2001 Jul 17;135(2):S-21. No abstract available. PMID: 11463005 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.

    Jafar TH, Schmid CH, Levey AS.

    Ann Intern Med. 2002 Aug 20;137(4):298-9. No abstract available. PMID: 12186531 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

    Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

    Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?

    Bakris GL.

    J Clin Hypertens (Greenwich). 2007 Jun;9(6):413-5. No abstract available. PMID: 17541325 [PubMed - indexed for MEDLINE]Related articles

    8.

    Questions and answers from controlled clinical trials of antihypertensive therapy in progressive renal disease.

    Kasiske BL.

    Am J Hypertens. 1992 Oct;5(10):778-9. Review. No abstract available. PMID: 1418845 [PubMed - indexed for MEDLINE]Related articles

    9.

    Angiotensin converting enzyme inhibitors in nondiabetic renal disease.

    Maschio G, Marcantoni C.

    Curr Opin Nephrol Hypertens. 1998 May;7(3):253-7. Review.PMID: 9617554 [PubMed - indexed for MEDLINE]Related articles

    10.

    WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.

    Lovell HG.

    Cochrane Database Syst Rev. 2007 Jul 18;(1):CD002183. Review.PMID: 17636698 [PubMed - indexed for MEDLINE]Related articles

    12.

    [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]

    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

    Presse Med. 2002 Nov 9;31(36):1714-20. Review. French. PMID: 12467154 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

    Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ.

    Lancet. 2005 Dec 10;366(9502):2026-33. Review.PMID: 16338452 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of different blood-pressure-lowering regimens on major cardiac events.

    Steffen HM, Toex U, Kolloch R.

    Lancet. 2004 Jan 24;363(9405):331; author reply 331-2. No abstract available. PMID: 14751718 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Angiotensin converting enzyme inhibitors in renal diseases]

    Shestakova MV, Kutyrina IM.

    Kardiologiia. 2002;42(9):74-9. Russian. PMID: 12494080 [PubMed - indexed for MEDLINE]Related articles

    16.

    Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.

    Myers BD, Boothroyd D, Olshen RA.

    J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S66-70. Review.PMID: 11443771 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antihypertensive agents for preventing diabetic kidney disease.

    Strippoli GF, Craig M, Craig JC.

    Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004136. Review.PMID: 16235351 [PubMed - indexed for MEDLINE]Related articles

    18.

    Constructing a database of individual clinical trials for longitudinal analysis.

    Schmid CH, Landa M, Jafar TH, Giatras I, Karim T, Reddy M, Stark PC, Levey AS; Angiotensin-Converting Enzyme Inhibition in Progressive Renal Disease (AIPRD) Study Group.

    Control Clin Trials. 2003 Jun;24(3):324-40.PMID: 12757997 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

    Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease.

    Kidney Int. 2001 Sep;60(3):1131-40.PMID: 11532109 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

    MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

    Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.PMID: 16797382 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data